HRR Testing & PARPi Underutilized in Patients With Metastatic Prostate Cancer
Only half of patients with metastatic castration-resistant prostate cancer were tested for HRR mutations, and PARP inhibitors were underused.
Read MoreApr 11, 2024
Only half of patients with metastatic castration-resistant prostate cancer were tested for HRR mutations, and PARP inhibitors were underused.
Read MoreApr 11, 2024
A regional collaborative involving universal decolonization in long-term care facilities and...
Read MoreApr 11, 2024
Inappropriate diagnosis of community-acquired pneumonia (CAP) in hospitalized adults is common,...
Read MoreApr 11, 2024
Results showed that patients with a high Immunoscore exhibited significantly better overall survival and recurrence-free survival.
Read MoreApr 11, 2024
Dr. Eiry Roberts discusses why clinicians should avoid anticholinergics in patients with tardive...
Read MoreApr 10, 2024
RSV was associated with nearly 10% of outpatient COPD exacerbations in a study of nearly 2,000...
Read MoreApr 10, 2024
An adjuvanted RSV vaccine has the potential to significantly decrease the burden of RSV among...
Read MoreApr 9, 2024
Comprehensive and diverse datasets, including rare and precancerous lesions, are needed for skin cancer diagnosis and treatment with artificial intelligence.
Read MoreApr 9, 2024
New studies show that medications for type 2 diabetes are not always prescribed to patients in accordance with guideline recommendations.
Read MoreApr 8, 2024
For people with a history of suboptimal ART adherence, long-acting injectable treatment (LAI) is...
Read MoreApr 8, 2024
Nurse-led management can lower cardiovascular risk factors among individuals with HIV receiving...
Read MoreApr 8, 2024
Young adults with perinatally acquired HIV experience a high incidence of five chronic...
Read MoreApr 5, 2024
Depression impacted treatment decisions and outcomes in patients with psoriatic arthritis, according to recent findings.
Read MoreApr 4, 2024
In this firsthand tale of secret vendettas, a nurse with a sinister side shares secrets of retaliation against those who crossed her within the hospital walls.
Read MoreApr 4, 2024
SDOH play a pivotal role in shaping the landscape of neurologic diseases and outcomes.
Read MoreApr 3, 2024
Men with metastatic hormone-sensitive prostate cancer who experience baseline bone pain have worse survival outcomes despite treatment intensification.
Read MoreApr 1, 2024
Results showed that patients with a high Immunoscore exhibited significantly better overall survival and recurrence-free survival.
Read MoreMar 29, 2024
Various sessions at the 2024 ASCO Genitourinary Cancers Symposium reviewed health care discrimination and disparities among patients with prostate cancer.
Read More